Report Detail

Pharma & Healthcare 2018-2023 Global Brand Drugs Consumption Market Report

  • RnM2475686
  • |
  • 12 October, 2018
  • |
  • Global
  • |
  • 165 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

2018-2023 Global Brand Drugs Consumption Market Report

Table of Contents

    2018-2023 Global Brand Drugs Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Brand Drugs Consumption 2013-2023
        • 2.1.2 Brand Drugs Consumption CAGR by Region
      • 2.2 Brand Drugs Segment by Type
        • 2.2.1 Biopharmaceutical
        • 2.2.2 Chemistry Medicine
      • 2.3 Brand Drugs Consumption by Type
        • 2.3.1 Global Brand Drugs Consumption Market Share by Type (2013-2018)
        • 2.3.2 Global Brand Drugs Revenue and Market Share by Type (2013-2018)
        • 2.3.3 Global Brand Drugs Sale Price by Type (2013-2018)
      • 2.4 Brand Drugs Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Clinic
        • 2.4.3 Other
      • 2.5 Brand Drugs Consumption by Application
        • 2.5.1 Global Brand Drugs Consumption Market Share by Application (2013-2018)
        • 2.5.2 Global Brand Drugs Value and Market Share by Application (2013-2018)
        • 2.5.3 Global Brand Drugs Sale Price by Application (2013-2018)

      3 Global Brand Drugs by Players

      • 3.1 Global Brand Drugs Sales Market Share by Players
        • 3.1.1 Global Brand Drugs Sales by Players (2016-2018)
        • 3.1.2 Global Brand Drugs Sales Market Share by Players (2016-2018)
      • 3.2 Global Brand Drugs Revenue Market Share by Players
        • 3.2.1 Global Brand Drugs Revenue by Players (2016-2018)
        • 3.2.2 Global Brand Drugs Revenue Market Share by Players (2016-2018)
      • 3.3 Global Brand Drugs Sale Price by Players
      • 3.4 Global Brand Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Brand Drugs Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Brand Drugs Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Brand Drugs by Regions

      • 4.1 Brand Drugs by Regions
        • 4.1.1 Global Brand Drugs Consumption by Regions
        • 4.1.2 Global Brand Drugs Value by Regions
      • 4.2 Americas Brand Drugs Consumption Growth
      • 4.3 APAC Brand Drugs Consumption Growth
      • 4.4 Europe Brand Drugs Consumption Growth
      • 4.5 Middle East & Africa Brand Drugs Consumption Growth

      5 Americas

      • 5.1 Americas Brand Drugs Consumption by Countries
        • 5.1.1 Americas Brand Drugs Consumption by Countries (2013-2018)
        • 5.1.2 Americas Brand Drugs Value by Countries (2013-2018)
      • 5.2 Americas Brand Drugs Consumption by Type
      • 5.3 Americas Brand Drugs Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Brand Drugs Consumption by Countries
        • 6.1.1 APAC Brand Drugs Consumption by Countries (2013-2018)
        • 6.1.2 APAC Brand Drugs Value by Countries (2013-2018)
      • 6.2 APAC Brand Drugs Consumption by Type
      • 6.3 APAC Brand Drugs Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Brand Drugs by Countries
        • 7.1.1 Europe Brand Drugs Consumption by Countries (2013-2018)
        • 7.1.2 Europe Brand Drugs Value by Countries (2013-2018)
      • 7.2 Europe Brand Drugs Consumption by Type
      • 7.3 Europe Brand Drugs Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Brand Drugs by Countries
        • 8.1.1 Middle East & Africa Brand Drugs Consumption by Countries (2013-2018)
        • 8.1.2 Middle East & Africa Brand Drugs Value by Countries (2013-2018)
      • 8.2 Middle East & Africa Brand Drugs Consumption by Type
      • 8.3 Middle East & Africa Brand Drugs Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Brand Drugs Distributors
      • 10.3 Brand Drugs Customer

      11 Global Brand Drugs Market Forecast

      • 11.1 Global Brand Drugs Consumption Forecast (2018-2023)
      • 11.2 Global Brand Drugs Forecast by Regions
        • 11.2.1 Global Brand Drugs Forecast by Regions (2018-2023)
        • 11.2.2 Global Brand Drugs Value Forecast by Regions (2018-2023)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Brand Drugs Forecast by Type
      • 11.8 Global Brand Drugs Forecast by Application

      12 Key Players Analysis

      • 12.1 Pfizer
        • 12.1.1 Company Details
        • 12.1.2 Brand Drugs Product Offered
        • 12.1.3 Pfizer Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.1.4 Main Business Overview
        • 12.1.5 Pfizer News
      • 12.2 Roche
        • 12.2.1 Company Details
        • 12.2.2 Brand Drugs Product Offered
        • 12.2.3 Roche Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.2.4 Main Business Overview
        • 12.2.5 Roche News
      • 12.3 Sanofi
        • 12.3.1 Company Details
        • 12.3.2 Brand Drugs Product Offered
        • 12.3.3 Sanofi Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sanofi News
      • 12.4 Johnson & Johnson
        • 12.4.1 Company Details
        • 12.4.2 Brand Drugs Product Offered
        • 12.4.3 Johnson & Johnson Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.4.4 Main Business Overview
        • 12.4.5 Johnson & Johnson News
      • 12.5 Merck & Co. (MSD)
        • 12.5.1 Company Details
        • 12.5.2 Brand Drugs Product Offered
        • 12.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.5.4 Main Business Overview
        • 12.5.5 Merck & Co. (MSD) News
      • 12.6 Novartis
        • 12.6.1 Company Details
        • 12.6.2 Brand Drugs Product Offered
        • 12.6.3 Novartis Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.6.4 Main Business Overview
        • 12.6.5 Novartis News
      • 12.7 AbbVie
        • 12.7.1 Company Details
        • 12.7.2 Brand Drugs Product Offered
        • 12.7.3 AbbVie Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.7.4 Main Business Overview
        • 12.7.5 AbbVie News
      • 12.8 Gilead Sciences
        • 12.8.1 Company Details
        • 12.8.2 Brand Drugs Product Offered
        • 12.8.3 Gilead Sciences Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.8.4 Main Business Overview
        • 12.8.5 Gilead Sciences News
      • 12.9 GlaxoSmithKline (GSK)
        • 12.9.1 Company Details
        • 12.9.2 Brand Drugs Product Offered
        • 12.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.9.4 Main Business Overview
        • 12.9.5 GlaxoSmithKline (GSK) News
      • 12.10 Amgen
        • 12.10.1 Company Details
        • 12.10.2 Brand Drugs Product Offered
        • 12.10.3 Amgen Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.10.4 Main Business Overview
        • 12.10.5 Amgen News
      • 12.11 AstraZeneca
      • 12.12 Bristol-Myers Squibb
      • 12.13 Eli Lilly
      • 12.14 Teva
      • 12.15 Bayer
      • 12.16 Novo Nordisk
      • 12.17 Allergan
      • 12.18 Shire
      • 12.19 Boehringer Ingelheim
      • 12.20 Takeda

      13 Research Findings and Conclusion

      In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Brand Drugs market for 2018-2023.

      A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
      Over the next five years, LPI(LP Information) projects that Brand Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

      This report presents a comprehensive overview, market shares, and growth opportunities of Brand Drugs market by product type, application, key manufacturers and key regions.

      To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

      Segmentation by product type:
      Biopharmaceutical
      Chemistry Medicine
      Segmentation by application:
      Hospital
      Clinic
      Other

      This report also splits the market by region:
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
      Pfizer
      Roche
      Sanofi
      Johnson & Johnson
      Merck & Co. (MSD)
      Novartis
      AbbVie
      Gilead Sciences
      GlaxoSmithKline (GSK)
      Amgen
      AstraZeneca
      Bristol-Myers Squibb
      Eli Lilly
      Teva
      Bayer
      Novo Nordisk
      Allergan
      Shire
      Boehringer Ingelheim
      Takeda

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Brand Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
      To understand the structure of Brand Drugs market by identifying its various subsegments.
      Focuses on the key global Brand Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Brand Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Brand Drugs submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.


      Summary:
      Get latest Market Research Reports on Brand Drugs . Industry analysis & Market Report on Brand Drugs is a syndicated market report, published as 2018-2023 Global Brand Drugs Consumption Market Report. It is complete Research Study and Industry Analysis of Brand Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,660.00
      $6,990.00
      $9,320.00
      3,716.76
      5,575.13
      7,433.51
      4,160.34
      6,240.51
      8,320.68
      505,339.72
      758,009.58
      1,010,679.44
      325,010.77
      487,516.15
      650,021.54
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report